vs
Side-by-side financial comparison of AMERICAN BATTERY TECHNOLOGY Co (ABAT) and Bolt Biotherapeutics, Inc. (BOLT). Click either name above to swap in a different company.
AMERICAN BATTERY TECHNOLOGY Co is the larger business by last-quarter revenue ($4.8M vs $2.5M, roughly 1.9× Bolt Biotherapeutics, Inc.). AMERICAN BATTERY TECHNOLOGY Co runs the higher net margin — -195.0% vs -265.2%, a 70.3% gap on every dollar of revenue.
American Battery Technology Company, formerly American Battery Metals Corporation, is a US-based battery recycling technology startup founded in 2011. It employs a hydrometallurgical process to recycle batteries and a targeted extraction system to extract raw materials from primary resources.
Bolt Biotherapeutics, Inc. is a clinical-stage biotechnology company specializing in immune-stimulating antibody conjugate (ISAC) therapies for cancer treatment. Its core pipeline targets hard-to-treat solid tumors, serving global oncology markets and advancing novel immunotherapies that trigger targeted anti-tumor immune responses to improve patient outcomes.
ABAT vs BOLT — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $4.8M | $2.5M |
| Net Profit | $-9.3M | $-6.6M |
| Gross Margin | -33.6% | — |
| Operating Margin | -207.5% | -283.4% |
| Net Margin | -195.0% | -265.2% |
| Revenue YoY | 1331.8% | — |
| Net Profit YoY | 30.7% | 58.4% |
| EPS (diluted) | $-0.07 | $-9.38 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $4.8M | $2.5M | ||
| Q3 25 | $937.6K | $2.2M | ||
| Q2 25 | $2.8M | $1.8M | ||
| Q1 25 | $980.0K | $1.2M | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $1.1M | ||
| Q2 24 | — | $1.3M | ||
| Q1 24 | — | $5.3M |
| Q4 25 | $-9.3M | $-6.6M | ||
| Q3 25 | $-10.3M | $-7.1M | ||
| Q2 25 | $-10.2M | $-8.6M | ||
| Q1 25 | $-11.5M | $-11.0M | ||
| Q4 24 | — | $-15.9M | ||
| Q3 24 | — | $-15.2M | ||
| Q2 24 | — | $-21.2M | ||
| Q1 24 | — | $-10.8M |
| Q4 25 | -33.6% | — | ||
| Q3 25 | -375.1% | — | ||
| Q2 25 | -92.6% | — | ||
| Q1 25 | -274.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -207.5% | -283.4% | ||
| Q3 25 | -1080.8% | -355.1% | ||
| Q2 25 | -280.1% | -510.5% | ||
| Q1 25 | -1086.3% | -991.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -1441.1% | ||
| Q2 24 | — | -1772.3% | ||
| Q1 24 | — | -324.1% |
| Q4 25 | -195.0% | -265.2% | ||
| Q3 25 | -1098.5% | -329.4% | ||
| Q2 25 | -366.4% | -474.6% | ||
| Q1 25 | -1173.1% | -903.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -1330.1% | ||
| Q2 24 | — | -1662.4% | ||
| Q1 24 | — | -205.0% |
| Q4 25 | $-0.07 | $-9.38 | ||
| Q3 25 | $-0.09 | $-3.72 | ||
| Q2 25 | $-0.09 | $-4.46 | ||
| Q1 25 | $-0.14 | $-0.29 | ||
| Q4 24 | — | $-13.73 | ||
| Q3 24 | — | $-7.93 | ||
| Q2 24 | — | $-11.12 | ||
| Q1 24 | — | $-0.28 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $47.9M | $27.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $119.0M | $26.5M |
| Total Assets | $123.3M | $56.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $47.9M | $27.5M | ||
| Q3 25 | $30.9M | $31.9M | ||
| Q2 25 | $7.5M | $34.8M | ||
| Q1 25 | $7.8M | $38.8M | ||
| Q4 24 | — | $47.3M | ||
| Q3 24 | — | $53.8M | ||
| Q2 24 | — | $73.7M | ||
| Q1 24 | — | $91.3M |
| Q4 25 | $119.0M | $26.5M | ||
| Q3 25 | $96.0M | $32.1M | ||
| Q2 25 | $70.6M | $38.8M | ||
| Q1 25 | $65.6M | $46.8M | ||
| Q4 24 | — | $57.2M | ||
| Q3 24 | — | $72.0M | ||
| Q2 24 | — | $85.9M | ||
| Q1 24 | — | $104.2M |
| Q4 25 | $123.3M | $56.7M | ||
| Q3 25 | $101.5M | $65.1M | ||
| Q2 25 | $84.5M | $75.5M | ||
| Q1 25 | $76.5M | $85.9M | ||
| Q4 24 | — | $99.6M | ||
| Q3 24 | — | $109.3M | ||
| Q2 24 | — | $124.2M | ||
| Q1 24 | — | $142.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-9.8M | $-7.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-9.8M | $-7.2M | ||
| Q3 25 | $-7.1M | $-9.7M | ||
| Q2 25 | — | $-9.6M | ||
| Q1 25 | $-10.3M | $-13.4M | ||
| Q4 24 | — | $-14.4M | ||
| Q3 24 | — | $-14.0M | ||
| Q2 24 | — | $-16.1M | ||
| Q1 24 | — | $-16.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-14.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -1227.6% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.6% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
